news Scientists develop retina-on-a-chip to study eye diseases 28 August 2019 | By Victoria Rees (Drug Target Review) Combining organoid and organ-on-a-chip technologies, researchers have created a model which will allow them to study eye diseases and treatments for the retina.
news Researchers discover bronchospasms mechanisms using microdevice 26 August 2019 | By Victoria Rees (Drug Target Review) A ‘bronchi-on-a-chip’ has been created by researchers to identify the processes of bronchospasms which could aid in respiratory disease therapies.
news Organ-on-an-electronic-chip could be used in drug development 23 August 2019 | By Victoria Rees (Drug Target Review) Researchers have created a new organoid model that can be used to study systems such as the heart and the effects of drugs on these cells.
article Five latest developments for models 10 July 2019 | By Victoria Rees (Drug Target Review) The use of models is a key feature of preclinical studies and in recent months there have been several new advancements in this area. This article investigates five of the latest developments.
news Researchers develop biosensor with real-time oxygen monitoring 21 August 2018 | By Iqra Farooq (Drug Target Review) In a study, researchers have developed a biosensor concept using organs-on-a-chip to measure the levels of oxygen in real-time...
article Expert view: Rising growth of the global high‑content screening software and services market 11 June 2018 | By Jeff McMillan (Senior Product Manager Imaging at Molecular Devices) The global high-content screening (HCS) software and services market accounted for over $500 million in 2017 and is expected to reach approximately $1.4 billion by 2026, increasing at a compound annual growth rate of more than 11%, says Jeff McMillan, Senior Product Manager Imaging, Molecular Devices.
news ELRIG UK hosts inaugural Discovery Technologies event 8 May 2018 | By ELRIG ELRIG (European Laboratory Research & Innovation Group) has announced its first Discovery Technologies meeting, which will take place at Alderley Park, located near Macclesfield in Cheshire.
news ALS researchers begin recreating human spinal cords on a chip 30 April 2018 | By Dr Zara Kassam (Drug Target Review) NIH-funded study closes in on personalised drug testing for neurological disorders...
news Effective drug transfer tests look promising for placenta-on-a-chip technology 21 February 2018 | By Drug Target Review Researchers in America have demonstrated the feasibility of their ‘placenta-on-a-chip’ platform in studying how drugs are transported across the human placental barrier.
news Organ-on-chip technology tests for hepatitis B virus 16 February 2018 | By Dr Zara Kassam (Drug Target Review) Scientists have become the first in the world to test how pathogens interact with artificial human organs...
news Blood-vessel-on-a-chip provides insight into new anti-inflammatory drug candidate 17 January 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have discovered that synthetic APC-mimicking molecules provide anti-inflammatory and anti-thrombotic protection to endothelial cells without interfering with blood clotting...
news Organ-on-a-chip device successfully models heart disease 2 January 2018 | By Dr Zara Kassam (Drug Target Review) A new device that models atherosclerosis can help researchers better understand the disease, develop therapies and diagnose blood health...
news Stem cell-derived intestine model mimics innate immune responses 1 December 2017 | By Drug Target Review A stem cell-derived in vitro model displays key small intestine characteristics including innate immune responses.
news NIH awards $15m to support development of 3-D human tissue models 13 September 2017 | By Dr Zara Kassam (Drug Target Review) The NIH has announced 13 two-year awards totalling $15m, to develop 3-D microphysiological system platforms that model human disease...
news Researchers develop 3-D-printed biomaterials that degrade on demand 8 September 2017 | By Dr Zara Kassam (Drug Target Review) Engineers have demonstrated a technique for making 3-D-printed biomaterials that can degrade on demand, which can be useful in making intricately patterned microfluidic devices...
